Warren Graham W, Ostroff Jamie S, Goffin John R
From the Departments of Radiation Oncology and Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Am Soc Clin Oncol Educ Book. 2016;35:223-9. doi: 10.1200/EDBK_158704.
Tobacco use is the largest preventable risk factor for the development of several cancers, and continued tobacco use by patients with cancer and survivors of cancer causes adverse outcomes. Worldwide tobacco control efforts have reduced tobacco use and improved health outcomes in many countries, but several countries continue to suffer from increased tobacco use and associated adverse health effects. Continued tobacco use by patients undergoing cancer screening or treatment results in continued risk for cancer-related and noncancer-related health conditions. Although integrating tobacco assessment and cessation support into lung cancer screening and cancer care is well justified and feasible, most patients with cancer unfortunately do not receive evidence-based tobacco cessation support. Combining evidence-based methods of treating tobacco addiction, such as behavioral counseling and pharmacotherapy, with practical clinical considerations in the setting of lung cancer screening and cancer treatment should result in substantial improvements in access to evidence-based care and resultant improvements in health risks and cancer treatment outcomes.
烟草使用是多种癌症发生的最大可预防风险因素，癌症患者和癌症幸存者持续使用烟草会导致不良后果。全球烟草控制努力在许多国家减少了烟草使用并改善了健康状况，但仍有几个国家的烟草使用呈上升趋势，并伴有相关不良健康影响。接受癌症筛查或治疗的患者持续使用烟草会导致患癌症相关和非癌症相关健康疾病的风险持续存在。尽管将烟草评估和戒烟支持纳入肺癌筛查和癌症护理有充分的理由且可行，但不幸的是，大多数癌症患者并未获得基于证据的戒烟支持。将基于证据的治疗烟草成瘾方法，如行为咨询和药物治疗，与肺癌筛查和癌症治疗背景下的实际临床考虑相结合，应能大幅改善获得基于证据的护理的机会，并进而改善健康风险和癌症治疗结果。
